Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
Address
7380 COCA COLA DRIVE
HANOVER, MD 21076
Founded
2011
Number of Employees
13
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at PCSA make a trade.
Creating a free account takes less than one minute